Sigrid Hatse

8PUBLICATIONS
76CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 25, 2025
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Kristien Borremans, Anirudh Pabba, Gitte Zels

|Dec 02, 2025
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer.

François Richard, Marion Maetens, Karen Van Baelen

|Sep 09, 2023
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors.

Yentl Lambrechts, Sigrid Hatse, François Richard

|Aug 11, 2023
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez

|Jun 28, 2023
Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 4198.

Gwen Schroyen, Jeroen Blommaert, Donatienne van Weehaeghe

|Feb 02, 2023
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.

Patricia Altea-Manzano, Ginevra Doglioni, Yawen Liu

Pageof 2

Frequent Collaborators

6 joint publications

Hans Wildiers

4 joint publications

François Richard

3 joint publications

Christine Desmedt

3 joint publications

Diether Lambrechts